CELL THERAPY LIMITED
Significant control: Cardiogeni PLC (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cell Therapy Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Cell Therapy Limited sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CELL THERAPY LIMITED is an active private limited company (company number 06970743) incorporated on 23 July 2009, registered in Stratford-Upon-Avon. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£3.78m and cash of £30k, with 2 employees on average. Net assets rose 65% on the prior period (−£10.68m).
By net assets it sits in the bottom quarter of 64 comparable companies in Coventry (median £1,186, upper quartile £30k).
Ownership and control
- Cardiogeni Plc
- has significant influence or control
- has significant influence or control
- Dr Mubasher Shiekh
- owns 25–50% of shares
- holds 25–50% of voting rights
- Trevor Ajan Reginald
- owns 25–50% of shares
- holds 25–50% of voting rights
- Sir Martin John Evans
- owns 25–50% of shares
- holds 25–50% of voting rights
- Celixir Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 23 July 200917 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 6 August 2027in 286 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£3.78m | £30k | £447k | — | — | — | 2 |
| 31 March 2024 | −£10.68m | £153k | £454k | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-3,779,356 at 31 March 2025
- Net assets up 10% or more on the prior period+64.6% vs prior period
- Incorporated five or more years agoIncorporated 23 July 2009
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 286 days
- Next accounts duein 68 days
- Accounts period endNet liabilities £3.78m · small accounts
- Accounts period endNet liabilities £10.68m · small accounts
- Incorporated
Similar companies in Coventry
- POWERTRAIN DYNAMICS LTDAvon Dassett · inc. Oct 2009
- INSPECTION TECHNOLOGIES LTDLeamington Spa · inc. Oct 2009
- EMERALD AUTOMOTIVE DESIGN LIMITEDCoventry · inc. Oct 2009
- THE MANUFACTURING TECHNOLOGY CENTRE LIMITEDCoventry · inc. Feb 2009
- RICCO ASSOCIATES LIMITEDNuneaton · inc. May 2010
- ESPIRITA LIMITEDCoventry · inc. Sept 2008
All companies incorporated on 23 July 2009 · in Jul 2009.
Reminders for CELL THERAPY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.